← Back to Search

Time-Restricted Feeding for Cardiovascular Disease Risk Factors

N/A
Recruiting
Led By Courtney M. Peterson, Ph.D.
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 30-65 years old
Prediabetic as determined by HbA1c between 5.7-6.4% or fasting glucose between 100-125 mg/dl
Must not have
Lost or gained more than 3 kg of weight in the past 3 months
Sleep disorder, circadian disorder, or regularly sleep less than 6 hours per night
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks

Summary

This trial is testing whether eating only during certain hours of the day (time-restricted eating) can help people with prediabetes control their blood sugar, lose weight, and improve heart health. Participants will follow different eating schedules for a few months to see which is most effective. Time-restricted eating (TRE) is an emerging dietary intervention for weight loss and metabolic health, with various studies investigating its effects on body weight, fat oxidation, and heart health.

Who is the study for?
This trial is for adults aged 30-65 with a BMI of 27-43 who regularly wake up between 5-8 am and are prediabetic. It's not suitable for those with psychiatric conditions, significant diseases, recent weight fluctuations, or on certain medications affecting glucose or blood pressure.
What is being tested?
The study tests if eating within specific hours (Early TRF: ~8 am-3 pm; Mid-day TRF: ~1 pm - 8 pm) versus a control schedule (~8 am - 8 pm) affects blood sugar control, blood pressure, and cardiovascular risk factors over a period of 10 weeks.
What are the potential side effects?
Since the intervention involves dietary changes rather than medication, side effects may include hunger outside of eating windows, potential temporary changes in energy levels or mood due to adjustment to new eating patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 65 years old.
Select...
My blood sugar levels indicate I am prediabetic.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have lost or gained more than 3 kg in the last 3 months.
Select...
I have a sleep disorder or usually sleep less than 6 hours.
Select...
I have a serious stomach or gut condition, had major surgery on it, or have gallstones.
Select...
I have been diagnosed with cancer in the past 5 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Beta-cell responsivity index (a measure of beta-cell function)
C-Peptide
Glucose AUCs
+6 more
Secondary study objectives
8-isoprostane
Cortisol
Daily maximum value, minimum value, and amplitude of systolic and diastolic blood pressure
+4 more
Other study objectives
Adherence
Anxiety
Appetite
+18 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Mid-day TREExperimental Treatment1 Intervention
Group II: Early TREExperimental Treatment1 Intervention
Group III: Control SchedulePlacebo Group1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for prediabetes include lifestyle modifications such as dietary changes, increased physical activity, and sometimes pharmacological interventions. Dietary changes often focus on reducing calorie intake, improving the quality of consumed carbohydrates, and increasing fiber intake. Time-restricted eating (TRE), a form of intermittent fasting, aligns eating patterns with circadian rhythms, potentially enhancing insulin sensitivity and improving glycemic control. Physical activity helps increase insulin sensitivity and aids in weight management. Pharmacological treatments, like metformin, work by improving insulin sensitivity and reducing glucose production in the liver. These interventions are crucial for prediabetes patients as they can prevent the progression to type 2 diabetes and reduce the risk of associated cardiovascular diseases.
Meal frequency; does it determine postprandial lipaemia?Optimal Dietary Strategies for Prevention of Atherosclerotic Cardiovascular Disease in Diabetes: Evidence and Recommendations.The effect of diurnal distribution of carbohydrates and fat on glycaemic control in humans: a randomized controlled trial.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,337,309 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,231 Total Patients Enrolled
Courtney M. Peterson, Ph.D.Principal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
33 Total Patients Enrolled

Media Library

Control Schedule Clinical Trial Eligibility Overview. Trial Name: NCT03504683 — N/A
Prediabetes Research Study Groups: Mid-day TRE, Early TRE, Control Schedule
Prediabetes Clinical Trial 2023: Control Schedule Highlights & Side Effects. Trial Name: NCT03504683 — N/A
Control Schedule 2023 Treatment Timeline for Medical Study. Trial Name: NCT03504683 — N/A
~5 spots leftby Mar 2025